Hypotony in uveitis: an overview of medical and surgical management.

Autor:	Testi I; Uveitis and Scleritis Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK ilaria.testi@nhs.net.; Rheumatology Department, Great Ormond Street Hospital for Children, London, UK, London, UK., Calcagni A; Department of Electrophysiology, Moorfields Eye Hospital, National Health Service Foundation Trust, London, United Kingdom, London, UK., Barton K; UCL Institute of Ophthalmology, London, UK., Gooch J; Uveitis and Scleritis Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK., Petrushkin H; Uveitis and Scleritis Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK.; Rheumatology Department, Great Ormond Street Hospital for Children, London, UK, London, UK.
Jazyk:	angličtina
Zdroj:	The British journal of ophthalmology [Br J Ophthalmol] 2023 Nov 22; Vol. 107 (12), pp. 1765-1770. Date of Electronic Publication: 2023 Nov 22.
DOI:	10.1136/bjo-2022-322814
Abstrakt:	Hypotony is a well-recognised, sight-threatening complication of uveitis. It can also be the final common endpoint for a multitude of disease entities. Multiple mechanisms underlie hypotony, and meticulous clinical history alongside ocular phenotyping is necessary for choosing the best intervention and therapeutic management. In this narrative review, a comprehensive overview of medical and surgical treatment options for the management of non-surgically induced hypotony is provided. Management of ocular hypotony relies on the knowledge of the aetiology and mechanisms involved. An understanding of disease trajectory is vital to properly educate patients. Both anatomical and functional outcomes depend on the underlying pathophysiology and choice of treatment. Competing Interests: Competing interests: The authors have no relevant affiliations or financial involvement with any organisation or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. (© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu